EUROSETS
14.12.2022 14:57:40 CET | Business Wire | Press release
Eurosets, a company based in Medolla (Italy) leader in the development, production and commercialization of advanced medical devices, announces the first patient treated with Colibrì, the lightest extracorporeal life support (ECLS) system available in the market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214005502/en/
Colibrì in the operating room (Photo: Eurosets)
Colibrì received CE-Mark in October 2022 and complements and expands Eurosets ECLS portfolio with the objective to provide temporary support to patients suffering from ventricular failure, cardiac arrest or respiratory failure in a variety of different applications, including extracorporeal membrane oxygenation (ECMO), extracorporeal cardiopulmonary resuscitation (E-CPR) and mechanical circulatory support (MCS).
The first clinical procedure using Colibrì was performed by a team led by Pr Philippe Gaudard, head of the ICU department at the Arnaud de Villeneuve university Hospital of Montpellier, France. The patient was supported on VA-ECMO and successfully weaned after few days of treatment. “I truly believe that Colibrì has the potential to become the new standard of care for ECLS – said Dr. Gaudard –. Colibrì, with its lightweight design, ensures that ECLS can be delivered by the specialised mobile ECMO team whenever and wherever is needed and, through its unique features, allows us to initiate ECMO therapy in a safe, easy and reproducible way with advanced monitoring”.
Featuring a fully magnetic-levitating centrifugal pump that covers adult, paediatric and new-born patients, a series of advanced monitoring capabilities and a complete integration with ECMOLife, Colibrì is the lightest device available in the market. The breakthrough device developed by Eurosets is also the only one equipped with a wi-fi connection that allows innovative remote monitoring, thereby ensuring greater patient safety and easier management for healthcare professionals. A set of unique transport accessories, designed to perform ECLS even in the most difficult scenarios, makes Colibrì the only device available in the market truly able to perform ECLS treatments everywhere there is a life to save.
"We are proud to launch Colibrì, an innovative system that complements our ECLS offering – said Antonio Petralia, CEO and Executive Vice President of Eurosets – Our vision is to reimagine ECLS treatments while responding to diverse medical needs through meaningful innovation and Colibrì is fully in line with these core beliefs".
Colibrì is currently being introduced in selected European centers as part of a controlled launch, after which a full international commercial release will follow upon achievement of local approvals.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005502/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Smead Capital Management Extends International Value Strategy to Global Investors Through New Fund10.6.2026 09:00:00 CEST | Press release
Firm expands access to long-standing U.S.-based international strategy, bringing disciplined, value-driven investing to a broader global audience through the Smead Global ex-US Value UCITS Fund Smead Capital Management, a Phoenix-based investment management firm and a leader in value investing, today announced the launch of the Smead Global ex-US Value UCITS Fund designed to provide global investors with access to a product modeled after the firm’s long-standing Smead International Value Strategy. The Smead Global ex-US Value UCITS Fund is domiciled in Luxembourg. Investors can access the fund through Smead Capital Management’s website and it is available to professional and qualified investors through the fund’s transfer agent. The strategy that the Smead Global ex-US Value UCITS Fund is modeled after, the Smead International Value Strategy, has been a core contributor to Smead Capital Management’s outstanding performance for over a decade. Like all Smead products, the Global ex-US Va
Dodge Opens Orders for the Next Generation Charger in Europe10.6.2026 09:00:00 CEST | Press release
The iconic American muscle car returns with an all-electric and gasoline-powered lineup engineered without compromise Orders are now open in Europe for the next-generation Dodge Charger lineup The range includes the all-electric Dodge Charger Daytona and the gas-engine, SIXPACK-powered Dodge Charger Built on the STLA Large multi-energy platform, the new Charger delivers two distinct performance experiences rooted in the same Dodge DNA Available in both two-door and four-door body styles, with R/T and Scat Pack trims across both gasoline and all-electric versions European customers can order through KWA, Dodge’s official importer, using this link An Icon Enters Its Next Generation This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609386800/en/ Celebrating its 60th anniversary this year, Dodge opens a bold new chapter in Europe with the launch of the next-generation Dodge Charger, bringing one of America’s most iconic muscle c
Roquette Showcases Scalable Drug Delivery Innovations at CPHI China 202610.6.2026 09:00:00 CEST | Press release
Under the theme “One Roquette for Innovations,” the company will highlight its recently expanded portfolio to demonstrate how this unmatched range of high-performance excipients and innovative formulation solutions is powering the next generation of pharmaceuticals. Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, will showcase its comprehensive portfolio of innovative drug delivery solutions at CPHI & PMEC China 2026, taking place June 16-18 at the Shanghai New International Expo Centre (SNIEC). Under the theme “One Roquette for Innovations,” Roquette’s Health & Pharma Solutions Business Unit will exhibit at booth E3D26, highlighting how its deep scientific expertise and technical capabilities enable pharmaceutical companies to turn promising formulations into scalable commercial realities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610596225/en/ Visit Roquette at booth E3D26 to mee
Trustd Brings Know Your Carrier to Market as Freight Fraud Costs European Supply Chains Over €1bn10.6.2026 08:01:00 CEST | Press release
New web-based tool lets shippers and 3PLs verify carriers in seconds as cargo crime across Europe reaches record levels Trustd, the digital identity and credentials verification platform for transport and logistics, is bringing to market Know Your Carrier (KYC), a web-based verification tool that lets shippers and 3PLs get an instant risk signal on carriers quoting for work via email in seconds. Cargo crime across EMEA has risen 438% in three years. More than 108,000 supply chain thefts were recorded across the region in the last two years. Of the 5% that reported a financial loss, the combined value exceeded €1bn, equivalent to €1.3m every 24 hours. Know Your Carrier draws on Trustd's expertise in digital identity verification to address a problem that has until now had no industry-wide solution. The web-based tool plugs into existing workflows with no installation or integration. Users enter an email address and, where available, a VAT number. The tool checks email legitimacy and dom
Sofinnova Partners Launches Collaboration with AWS to Scale AI Across Life Sciences Innovation10.6.2026 08:00:00 CEST | Press release
Sofinnova combines its sector expertise with AWS’s AI and cloud services to help life sciences companies scale fasterThe collaboration expands Sofinnova’s proprietary AI platform, Sofia, including a new founder-facing version Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced a collaboration with Amazon Web Services (AWS), to embed AI more deeply across its investment platform and portfolio companies. The collaboration supports Sofinnova.AI, the firm’s initiative to integrate AI across its core activities, from sourcing and evaluating investments to supporting company building. At the center of this effort is Sofia, Sofinnova's proprietary AI platform, which will be extended beyond internal use to include a founder-facing version. Through this collaboration, Sofinnova-backed startups will gain access to tailored AWS resources and technical enablement, helping them move faster from early research to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom